218 related articles for article (PubMed ID: 38371502)
1. Fenugreek derived diosgenin as an emerging source for diabetic therapy.
Tak Y; Kaur M; Chitranashi A; Samota MK; Verma P; Bali M; Kumawat C
Front Nutr; 2024; 11():1280100. PubMed ID: 38371502
[TBL] [Abstract][Full Text] [Related]
2. Diosgenin: An ingress towards solving puzzle for diabetes treatment.
Arya P; Kumar P
J Food Biochem; 2022 Dec; 46(12):e14390. PubMed ID: 36106684
[TBL] [Abstract][Full Text] [Related]
3. Diosgenin ameliorates gestational diabetes through inhibition of sterol regulatory element-binding protein-1.
Hua S; Li Y; Su L; Liu X
Biomed Pharmacother; 2016 Dec; 84():1460-1465. PubMed ID: 27810341
[TBL] [Abstract][Full Text] [Related]
4. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats.
Liu L; Yang M; Lin X; Li Y; Liu C; Yang Y; Yamahara J; Wang J; Li Y
J Ethnopharmacol; 2013 Dec; 150(3):1045-52. PubMed ID: 24157375
[TBL] [Abstract][Full Text] [Related]
5. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells.
Fang K; Wu F; Chen G; Dong H; Li J; Zhao Y; Xu L; Zou X; Lu F
BMC Complement Altern Med; 2019 Sep; 19(1):255. PubMed ID: 31519174
[TBL] [Abstract][Full Text] [Related]
6. YiQi YangYin Decoction Attenuates Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Rats.
Li F; Liu G; Xue P; Ren Z; Dai P; Niu W; Xin M
Evid Based Complement Alternat Med; 2021; 2021():5511019. PubMed ID: 34621322
[TBL] [Abstract][Full Text] [Related]
7. Diosgenin, the main aglycon of fenugreek, inhibits LXRα activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice.
Uemura T; Goto T; Kang MS; Mizoguchi N; Hirai S; Lee JY; Nakano Y; Shono J; Hoshino S; Taketani K; Tsuge N; Narukami T; Makishima M; Takahashi N; Kawada T
J Nutr; 2011 Jan; 141(1):17-23. PubMed ID: 21106928
[TBL] [Abstract][Full Text] [Related]
8. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
[TBL] [Abstract][Full Text] [Related]
9. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
10. Diosgenin a steroidal compound: An emerging way to cancer management.
Arya P; Kumar P
J Food Biochem; 2021 Dec; 45(12):e14005. PubMed ID: 34799857
[TBL] [Abstract][Full Text] [Related]
11. Regulation of energy metabolism by long-chain fatty acids.
Nakamura MT; Yudell BE; Loor JJ
Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
[TBL] [Abstract][Full Text] [Related]
12. Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues.
Uemura T; Hirai S; Mizoguchi N; Goto T; Lee JY; Taketani K; Nakano Y; Shono J; Hoshino S; Tsuge N; Narukami T; Takahashi N; Kawada T
Mol Nutr Food Res; 2010 Nov; 54(11):1596-608. PubMed ID: 20540147
[TBL] [Abstract][Full Text] [Related]
13. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
14. Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet-streptozotocin-induced diabetic rats.
Naidu PB; Ponmurugan P; Begum MS; Mohan K; Meriga B; RavindarNaik R; Saravanan G
J Sci Food Agric; 2015 Dec; 95(15):3177-82. PubMed ID: 25530163
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
[TBL] [Abstract][Full Text] [Related]
16. Diosgenin and Its Fenugreek Based Biological Matrix Affect Insulin Resistance and Anabolic Hormones in a Rat Based Insulin Resistance Model.
Kiss R; Pesti-Asbóth G; Szarvas MM; Stündl L; Cziáky Z; Hegedűs C; Kovács D; Badale A; Máthé E; Szilvássy Z; Remenyik J
Biomed Res Int; 2019; 2019():7213913. PubMed ID: 31080828
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of Streptozotocin-Induced Lipid Profile Anomalies in the Heart, Brain, and mRNA Expression of HMG-CoA Reductase by Diosgenin in Rats.
Hao S; Xu R; Li D; Zhu Z; Wang T; Liu K
Cell Biochem Biophys; 2015 Jul; 72(3):741-9. PubMed ID: 25631375
[TBL] [Abstract][Full Text] [Related]
18. Diazoxide attenuates insulin secretion and hepatic lipogenesis in zucker diabetic fatty rats.
Alemzadeh R; Tushaus K
Med Sci Monit; 2005 Dec; 11(12):BR439-48. PubMed ID: 16319780
[TBL] [Abstract][Full Text] [Related]
19. Effect of Korean Red Ginseng on metabolic syndrome.
Yoon SJ; Kim SK; Lee NY; Choi YR; Kim HS; Gupta H; Youn GS; Sung H; Shin MJ; Suk KT
J Ginseng Res; 2021 May; 45(3):380-389. PubMed ID: 34025131
[TBL] [Abstract][Full Text] [Related]
20. Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats.
Tharaheswari M; Jayachandra Reddy N; Kumar R; Varshney KC; Kannan M; Sudha Rani S
Mol Cell Biochem; 2014 Nov; 396(1-2):161-74. PubMed ID: 25070833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
